Home Investors  >  Financials  >  Debt Securities

Debt Securities

Teva's senior notes and debentures and convertible debentures are issued by various special-purpose finance subsidiaries. All such debt is guaranteed by Teva Pharmaceutical Industries Ltd.

Senior Notes and Sustainability-Linked Senior Notes


Issued Currency Annual Interest
(%)
Principal Amount Issued
(issuance currency, in millions)
Outstanding Principal Amount
(issuance currency, in millions)
Outstanding Principal Amount
(U.S. $, in millions)
Due Prospectuses
July 2016 USD 3.150 3,500 1,798 1,798 October 2026
March 2015 Euro 1.875 700 700 794 March 2027
November 2021 Euro 3.750 1,100 1,100 1,248 May 2027
November 2021 USD 4.750 1,000 199 199 May 2027
July 2016 Euro 1.625 750 750 851 October 2028
November 2021 USD 5.125 1,000 1,000 1,000 May 2029
November 2021 Euro 4.375 1,500 350 397 May 2030
May 2025 USD 5.750 700 700 700 December 2030
May 2025 Euro 4.125 1,000 1,000 1,134 June 2031
March 2023 Euro 7.875 500 500 567 September 2031
March 2023 USD 8.125 500 - 0 September 2031
September 2026 USD 5.250 1,200 1,200 1,200 January 2032
May 2025 USD 6.000 500 500 500 December 2032
September 2026 EUR 4.250 1,000 1,000 1,134 March 2033
September 2026 USD 5.500 1,000 1,000 1000 January 2034
February 2006 USD 6.150 1,000 789 789 February 2036
September 2026 EUR 4.625 500 500 567 September 2036
September 2026 USD 5.750 1,000 1,000 1000 January 2037
July 2016 USD 4.100 2,000 2,000 2,000 October 2046